Implantable Cardiac Monitors in High-Risk Post-Infarction Patients With Cardiac Autonomic Dysfunction

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 400 participants.

Also called NCT02594488

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 400 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02594488
Other papers using this trial's data
  • Telemedical cardiac risk assessment by implantable cardiac monitors in patients after myocardial infarction with autonomic dysfunction (SMART-MI-DZHK9): a prospective investigator-initiated, randomised, multicentre, open-label, diagnostic trial The Lancet. Digital health, 2022-02 DOI, PubMed 35090674

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Austria, Germany (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02594488. Randomized; no masking; primary purpose diagnostic. Start 2016-05-06 (actual); primary completion 2021-02 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Implantable Cardiac Monitors in High-Risk Post-Infarction Patients With Cardiac Autonomic Dysfunction
Acronym
SMART-MI
Condition
Autonomic Nervous System Diseases
Intervention (Device)
Medtronic Reveal LINQ implantable cardiac monitor
Lead sponsor
LMU Klinikum (class: other)
Collaborator
Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK) (class: other)
Collaborator
Medtronic Cardiac Rhythm and Heart Failure (class: industry)

Record details

Record id
cardio:ct-nct02594488
Content hash
71568f56434fe6f5cecdd16a4c0e46ea63e86459b7f842c6029c8575ce2a1786